We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
Cap. Flow
+$161M
Cap. Flow %
6.13%
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$13.4M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$10.5M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$10M
4
MDCO
Medicines Co
MDCO
+$8.78M
5
TIF
Tiffany & Co.
TIF
+$7.91M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$42.5M
2
VSM
Versum Materials, Inc.
VSM
+$29.7M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$23.3M
4
AABA
Altaba Inc
AABA
+$18.8M
5
CPE
Callon Petroleum Company
CPE
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 4.59%
2 Healthcare 3.78%
3 Consumer Discretionary 3.06%
4 Communication Services 2.48%
5 Real Estate 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
1751
DELISTED
NanoString Technologies, Inc.
NSTG
$6K ﹤0.01%
201
-80
-28% -$1.94K
EV
1752
DELISTED
Eaton Vance Corp.
EV
$6K ﹤0.01%
122
-942
-89% -$43.6K
FBM
1753
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$6K ﹤0.01%
300
+100
+50% +$1.92K
DZSI
1754
DELISTED
DZS Inc. Common Stock
DZSI
$6K ﹤0.01%
641
-5,884
-90% -$46.4K
AIRG icon
1755
Airgain
AIRG
$72.4M
$5K ﹤0.01%
500
+256
+105% +$2.69K
CRON
1756
CALL
Cronos Group
CRON
$1.14B
$5K ﹤0.01%
600
– –
CUBI icon
1757
Customers Bancorp
CUBI
$2.77B
$5K ﹤0.01%
+224
New +$5.14K
CVM icon
1758
CALL
CEL-SCI Corp
CVM
$30.1M
$5K ﹤0.01%
+20
New +$4.72K
GEN icon
1759
PUT
Gen Digital
GEN
$17.5B
$5K ﹤0.01%
200
-3,300
-94% -$80.6K
GKOS icon
1760
Glaukos
GKOS
$10.6B
$5K ﹤0.01%
+84
New +$5.11K
GYRE icon
1761
Gyre Therapeutics
GYRE
$744M
$5K ﹤0.01%
+107
New +$4.48K
LILAK icon
1762
Liberty Latin America Class C
LILAK
$1.64B
$5K ﹤0.01%
+279
New +$4.32K
PFS icon
1763
Provident Financial Services
PFS
$3.19B
$5K ﹤0.01%
+193
New +$4.77K
PI icon
1764
Impinj
PI
$5.6B
$5K ﹤0.01%
+200
New +$6.22K
RICK icon
1765
RCI Hospitality Holdings
RICK
$215M
$5K ﹤0.01%
266
-600
-69% -$11.6K
RLMD icon
1766
Relmada Therapeutics
RLMD
$527M
$5K ﹤0.01%
+121
New +$3.68K
SCOR icon
1767
CALL
Comscore
SCOR
$109M
$5K ﹤0.01%
55
+25
+83% +$1.71K
SNBR
1768
DELISTED
Sleep Number
SNBR
$5K ﹤0.01%
+105
New +$4.99K
TENB icon
1769
Tenable Holdings
TENB
$4.01B
$5K ﹤0.01%
+200
New +$4.87K
USLM icon
1770
United States Lime & Minerals
USLM
$3.44B
$5K ﹤0.01%
+250
New +$4.39K
XGN icon
1771
Exagen
XGN
$166M
$5K ﹤0.01%
+200
New +$3.56K
CVET
1772
DELISTED
Covetrus, Inc. Common Stock
CVET
$5K ﹤0.01%
+344
New +$4.17K
MSBF
1773
DELISTED
MSB Financial Corp.
MSBF
$5K ﹤0.01%
+277
New +$4.43K
AGYS icon
1774
Agilysys
AGYS
$3.06B
$4K ﹤0.01%
171
-29
-15% -$734
EXEL icon
1775
CALL
Exelixis
EXEL
$13.4B
$4K ﹤0.01%
+200
New +$3.39K
69 70
71
72 73

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.

  • Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
  • Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
  • Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
  • Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
  • Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.